STOCK TITAN
  1. Home
  2. Sec-filings
  3. GUTS
  4. [Form 4] FRACTYL HEALTH, INC. Insider Trading Activity

Fractyl Health (GUTS) awards 22,500 stock options to board director

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

FRACTYL HEALTH, INC. director Samuel Conaway received a grant of stock options covering 22,500 shares of common stock at an exercise price of $0.7318 per share. These options were awarded as compensation for his board service and will vest in a single installment on the earlier of the next annual stockholder meeting or the first anniversary of the grant, subject to continued board service. Following this award, he holds 22,500 stock options directly.

Positive

  • None.

Negative

  • None.

Insights

Routine director stock option grant with standard vesting terms.

Director Samuel Conaway received 22,500 stock options for service on FRACTYL HEALTH, INC.'s board. The options have an exercise price of $0.7318 and expire on June 9, 2036, indicating long-dated equity compensation rather than a market transaction.

The footnote explains that vesting occurs in a single tranche on the earlier of the next annual stockholder meeting or the first anniversary of the grant, contingent on continued non-employee director service. This pattern is typical of non-employee director compensation policies and does not, by itself, signal a change in the company’s outlook.

Insider Conaway Samuel
Role Director
Type Security Shares Price Value
Grant/Award Stock Option 22,500 $0.00 --
Holdings After Transaction: Stock Option — 22,500 shares (Direct)
Footnotes (1)
  1. [object Object]
Stock options granted 22,500 options Grant for board service reported on Form 4
Exercise price $0.7318 per share Strike price of granted stock options
Expiration date June 9, 2036 Option term end date
Shares underlying options 22,500 shares Common stock underlying the stock option award
Holdings after transaction 22,500 options Total derivative holdings following this grant
Stock Option financial
"The stock option was awarded as compensation for the Reporting Person's service"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "0.7318""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
non-employee director compensation policy financial
"pursuant to the Issuer's non-employee director compensation policy"
vesting financial
"The stock option will vest and become exercisable in a single installment"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did director Samuel Conaway report in this Form 4 for FRACTYL HEALTH (GUTS)?
Director Samuel Conaway reported receiving a grant of stock options for 22,500 shares of FRACTYL HEALTH common stock. The options were awarded as compensation for his service on the company’s board of directors under its non-employee director compensation policy.

How many FRACTYL HEALTH (GUTS) stock options were granted to Samuel Conaway?
Samuel Conaway was granted stock options covering 22,500 shares of FRACTYL HEALTH common stock. This entire amount reflects a single option award, which is intended as equity compensation for his role as a non-employee director on the company’s board.

What is the exercise price and expiration date of Samuel Conaway’s FRACTYL HEALTH (GUTS) options?
The stock options granted to Samuel Conaway have an exercise price of $0.7318 per share and an expiration date of June 9, 2036. These terms define the cost and time window within which he may choose to exercise the options.

How and when do Samuel Conaway’s FRACTYL HEALTH (GUTS) options vest?
The options will vest and become exercisable in a single installment on the earlier of the next annual meeting of stockholders or the first anniversary of the grant. Vesting is conditioned on his continued service as a non-employee director through that vesting date.

Is Samuel Conaway’s FRACTYL HEALTH (GUTS) Form 4 transaction a market purchase or sale?
The Form 4 shows a grant of stock options as compensation, not a market purchase or sale of shares. The transaction is coded as a grant or award (code A), meaning it reflects equity compensation rather than open-market trading activity in FRACTYL HEALTH stock.

What are Samuel Conaway’s reported FRACTYL HEALTH (GUTS) option holdings after this grant?
After the reported grant, Samuel Conaway holds 22,500 stock options directly. This figure represents his total derivative holdings reported in this filing, all tied to the same option award linked to his FRACTYL HEALTH board service.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Conaway Samuel
(Last)(First)(Middle)
3 VAN DE GRAAFF DRIVE
SUITE 200
(Street)
BURLINGTON MASSACHUSETTS 01803
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
FRACTYL HEALTH, INC. [ GUTS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option$0.731806/10/2026A22,500 (1)06/09/2036Common Stock22,500$022,500D
Explanation of Responses:
1. The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.
/s/ Harith Rajagopalan, M.D., Ph.D., Attorney-in-fact06/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR